💊
İlaç Sektörü Hisseleri
İlaç Sektörü altında 513 Hisse Senedi
İlaç sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$3.5T
Toplam Piyasa Değeri
İlaç Sektörü Hisseleri
Sayfa 1/6 (Toplam: 513)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | $695.83B | $735.19 | 0.36% |
| JNJ | Johnson & Johnson | $428.83B | $178.06 | 0.50% |
| ABBV | AbbVie Inc. | $374.37B | $211.92 | 0.72% |
| MRK | Merck & Co., Inc. | $213.51B | $85.48 | 1.62% |
| TMO | Thermo Fisher Scientific Inc. | $184.10B | $487.53 | 1.05% |
| AMGN | Amgen Inc. | $154.47B | $286.92 | 0.27% |
| PFE | Pfizer Inc. | $142.03B | $24.98 | 0.89% |
| GILD | Gilead Sciences, Inc. | $139.85B | $112.71 | 0.23% |
| VRTX | Vertex Pharmaceuticals Incorporated | $102.81B | $401.00 | 2.55% |
| BMY | Bristol-Myers Squibb Company | $96.50B | $47.41 | 0.49% |
| CVS | CVS Health Corporation | $93.97B | $74.09 | 1.28% |
| MCK | McKesson Corporation | $86.03B | $691.62 | 0.73% |
| ZTS | Zoetis Inc. | $67.75B | $152.88 | 2.25% |
| REGN | Regeneron Pharmaceuticals, Inc. | $60.20B | $577.90 | 0.48% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $58.59B | $447.00 | 0.11% |
| VEEV | Veeva Systems Inc. | $44.12B | $269.98 | 0.29% |
| CAH | Cardinal Health, Inc. | $35.71B | $149.55 | 0.52% |
| INSM | Insmed Incorporated | $30.71B | $145.30 | 6.76% |
| STE | STERIS plc | $23.84B | $242.02 | 1.24% |
| BIIB | Biogen Inc. | $20.47B | $139.63 | 5.60% |
| UTHR | United Therapeutics Corporation | $18.31B | $404.81 | 32.83% |
| WST | West Pharmaceutical Services, Inc. | $17.53B | $243.74 | 1.30% |
| INCY | Incyte Corporation | $16.79B | $85.98 | 1.62% |
| NBIX | Neurocrine Biosciences, Inc. | $14.08B | $141.92 | 1.66% |
| MEDP | Medpace Holdings, Inc. | $13.30B | $473.34 | 0.46% |
| BAX | Baxter International Inc. | $12.41B | $24.17 | 2.11% |
| VTRS | Viatris Inc. | $12.31B | $10.56 | 0.09% |
| BMRN | BioMarin Pharmaceutical Inc. | $11.35B | $59.09 | 1.41% |
| WBA | Walgreens Boots Alliance, Inc. | $10.37B | $11.98 | 0.50% |
| EXEL | Exelixis, Inc. | $10.01B | $37.18 | 0.64% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $9.72B | $436.11 | 0.40% |
| BBIO | BridgeBio Pharma, Inc. | $9.56B | $50.00 | 3.40% |
| MRNA | Moderna, Inc. | $9.41B | $24.19 | 0.42% |
| IONS | Ionis Pharmaceuticals, Inc. | $9.16B | $57.49 | 34.84% |
| HIMS | Hims & Hers Health, Inc. | $9.04B | $41.53 | 1.94% |
| ELAN | Elanco Animal Health Incorporated | $8.87B | $17.85 | 2.72% |
| HALO | Halozyme Therapeutics, Inc. | $8.58B | $73.34 | 0.26% |
| BPMC | Blueprint Medicines Corporation | $8.36B | $129.46 | 0.14% |
| CORT | Corcept Therapeutics Incorporated | $7.52B | $71.38 | 2.38% |
| RVMD | Revolution Medicines, Inc. | $7.39B | $39.53 | 4.11% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $6.92B | $104.21 | 1.03% |
| RGEN | Repligen Corporation | $6.79B | $120.69 | 1.33% |
| AXSM | Axsome Therapeutics, Inc. | $6.16B | $123.47 | 1.81% |
| RNA | Avidity Biosciences, Inc. | $6.08B | $47.23 | 1.40% |
| CYTK | Cytokinetics, Incorporated | $5.94B | $49.62 | 40.45% |
| NUVL | Nuvalent, Inc. | $5.54B | $76.90 | 0.42% |
| GKOS | Glaukos Corporation | $5.39B | $93.95 | 1.95% |
| TGTX | TG Therapeutics, Inc. | $4.72B | $29.73 | 1.36% |
| OPCH | Option Care Health, Inc. | $4.62B | $28.44 | 0.84% |
| ACAD | ACADIA Pharmaceuticals Inc. | $4.33B | $25.69 | 1.15% |
| KRYS | Krystal Biotech, Inc. | $4.31B | $149.00 | 0.88% |
| PTCT | PTC Therapeutics, Inc. | $4.16B | $52.43 | 6.28% |
| ADMA | ADMA Biologics, Inc. | $4.10B | $17.20 | 0.35% |
| PCVX | Vaxcyte, Inc. | $4.10B | $31.56 | 2.50% |
| ACLX | Arcellx, Inc. | $3.87B | $69.75 | 0.52% |
| LNTH | Lantheus Holdings, Inc. | $3.76B | $55.29 | 0.71% |
| MIRM | Mirum Pharmaceuticals, Inc. | $3.73B | $74.34 | 0.64% |
| WGS | GeneDx Holdings Corp. | $3.68B | $128.18 | 1.01% |
| PTGX | Protagonist Therapeutics, Inc. | $3.66B | $58.85 | 0.34% |
| AKRO | Akero Therapeutics, Inc. | $3.63B | $45.44 | 2.76% |
| SLNO | Soleno Therapeutics, Inc. | $3.57B | $67.22 | 0.67% |
| APLS | Apellis Pharmaceuticals, Inc. | $3.56B | $28.17 | 2.18% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $3.55B | $25.68 | 16.57% |
| SWTX | SpringWorks Therapeutics, Inc. | $3.54B | $46.99 | 0.02% |
| PBH | Prestige Consumer Healthcare Inc. | $3.27B | $66.50 | 2.26% |
| LGND | Ligand Pharmaceuticals Incorporated | $3.21B | $163.73 | 1.25% |
| SRRK | Scholar Rock Holding Corporation | $3.18B | $33.12 | 1.44% |
| LEGN | Legend Biotech Corporation | $3.14B | $34.22 | 1.47% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $3.14B | $33.30 | 7.45% |
| ICUI | ICU Medical, Inc. | $3.14B | $127.02 | 0.50% |
| WRBY | Warby Parker Inc. | $3.12B | $25.55 | 2.48% |
| VKTX | Viking Therapeutics, Inc. | $3.09B | $27.49 | 1.63% |
| RARE | Ultragenyx Pharmaceutical Inc. | $3.09B | $32.03 | 6.91% |
| INDV | Indivior PLC | $3.07B | $24.60 | 1.32% |
| AMRX | Amneal Pharmaceuticals, Inc. | $3.01B | $9.58 | 0.21% |
| KYMR | Kymera Therapeutics, Inc. | $2.91B | $40.69 | 1.24% |
| XRAY | DENTSPLY SIRONA Inc. | $2.75B | $13.81 | 3.43% |
| IMVT | Immunovant, Inc. | $2.63B | $15.07 | 2.59% |
| CPRX | Catalyst Pharmaceuticals, Inc. | $2.51B | $20.54 | 0.24% |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.50B | $44.54 | 1.29% |
| TARS | Tarsus Pharmaceuticals, Inc. | $2.47B | $58.59 | 0.02% |
| LQDA | Liquidia Corporation | $2.46B | $28.58 | 3.25% |
| OGN | Organon & Co. | $2.45B | $9.42 | 0.00% |
| FOLD | Amicus Therapeutics, Inc. | $2.43B | $7.88 | 3.82% |
| VCYT | Veracyte, Inc. | $2.37B | $30.11 | 0.76% |
| AGIO | Agios Pharmaceuticals, Inc. | $2.28B | $39.25 | 4.08% |
| DNLI | Denali Therapeutics Inc. | $2.26B | $15.45 | 1.18% |
| IBRX | ImmunityBio, Inc. | $2.25B | $2.38 | 1.71% |
| IDYA | IDEAYA Biosciences, Inc. | $2.23B | $25.48 | 3.79% |
| CURLF | Curaleaf Holdings, Inc. | $2.23B | $2.92 | 11.24% |
| APGE | Apogee Therapeutics, Inc. | $2.22B | $37.86 | 4.10% |
| OCUL | Ocular Therapeutix, Inc. | $2.21B | $12.70 | 4.01% |
| IRON | Disc Medicine, Inc. | $2.13B | $61.40 | 2.94% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.13B | $37.10 | 0.57% |
| BLTE | Belite Bio, Inc | $2.12B | $64.90 | 2.97% |
| CGON | CG Oncology, Inc. Common stock | $2.09B | $27.46 | 2.39% |
| ANIP | ANI Pharmaceuticals, Inc. | $2.04B | $94.10 | 0.64% |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.99B | $4.66 | 0.85% |
| DYN | Dyne Therapeutics, Inc. | $1.92B | $13.50 | 0.07% |
| QDEL | QuidelOrtho Corporation | $1.92B | $28.25 | 1.53% |